S Grandl1, A Sztrókay-Gaul, S D Auweter, K Hellerhoff. 1. Institut für Klinische Radiologie, Klinikum der Ludwig-Maximilians-Universität München, Campus Großhadern, Marchioninistr. 15, 81377, München, Deutschland, susanne.grandl@med.uni-muenchen.de.
Abstract
CLINICAL/METHODICAL ISSUE: Breast cancer is the most common cancer and the leading cause of cancer deaths in women worldwide. STANDARD RADIOLOGICAL METHODS: Mammography is the only imaging technique approved for nationwide breast cancer screening. Digital full field mammography has improved mammographic image quality. Nevertheless, mammography has a low positive predictive value and a low sensitivity especially in mammographically dense breasts. One of the major limitations is the inherently low contrast between healthy breast parenchyma and breast cancer. METHODICAL INNOVATIONS: Phase contrast imaging is based on the phase shift that occurs when X-rays encounter a change in refractive index between different materials. PERFORMANCE: The improved soft tissue contrast makes the technology particularly promising for breast diagnostics. ACHIEVEMENTS: The studies presented here suggest that phase contrast imaging provides additional diagnostic information both using phase contrast mammography and phase contrast computed tomography (CT). PRACTICAL RECOMMENDATIONS: This paper provides an overview of the basic principles of the phase contrast imaging and describes recent developments towards in vivo and ex vivo phase contrast imaging of the breast.
CLINICAL/METHODICAL ISSUE: Breast cancer is the most common cancer and the leading cause of cancer deaths in women worldwide. STANDARD RADIOLOGICAL METHODS: Mammography is the only imaging technique approved for nationwide breast cancer screening. Digital full field mammography has improved mammographic image quality. Nevertheless, mammography has a low positive predictive value and a low sensitivity especially in mammographically dense breasts. One of the major limitations is the inherently low contrast between healthy breast parenchyma and breast cancer. METHODICAL INNOVATIONS: Phase contrast imaging is based on the phase shift that occurs when X-rays encounter a change in refractive index between different materials. PERFORMANCE: The improved soft tissue contrast makes the technology particularly promising for breast diagnostics. ACHIEVEMENTS: The studies presented here suggest that phase contrast imaging provides additional diagnostic information both using phase contrast mammography and phase contrast computed tomography (CT). PRACTICAL RECOMMENDATIONS: This paper provides an overview of the basic principles of the phase contrast imaging and describes recent developments towards in vivo and ex vivo phase contrast imaging of the breast.
Authors: F Arfelli; V Bonvicini; A Bravin; G Cantatore; E Castelli; L D Palma; M D Michiel; M Fabrizioli; R Longo; R H Menk; A Olivo; S Pani; D Pontoni; P Poropat; M Prest; A Rashevsky; M Ratti; L Rigon; G Tromba; A Vacchi; E Vallazza; F Zanconati Journal: Radiology Date: 2000-04 Impact factor: 11.105
Authors: Jani Keyriläinen; Alberto Bravin; Manuel Fernández; Mikko Tenhunen; Pekka Virkkunen; Pekka Suortti Journal: Acta Radiol Date: 2010-10 Impact factor: 1.990
Authors: Alberto Bravin; Jani Keyriläinen; Manuel Fernández; Stefan Fiedler; Christian Nemoz; Marja-Liisa Karjalainen-Lindsberg; Mikko Tenhunen; Pekka Virkkunen; Marjut Leidenius; Karl von Smitten; Petri Sipilä; Pekka Suortti Journal: Phys Med Biol Date: 2007-03-29 Impact factor: 3.609
Authors: Gisela Anton; Florian Bayer; Matthias W Beckmann; Jürgen Durst; Peter A Fasching; Wilhelm Haas; Arndt Hartmann; Thilo Michel; Georg Pelzer; Marcus Radicke; Claudia Rauh; Jens Rieger; André Ritter; Rüdiger Schulz-Wendtland; Michael Uder; David L Wachter; Thomas Weber; Evelyn Wenkel; Lukas Wucherer Journal: Z Med Phys Date: 2013-02-04 Impact factor: 4.820
Authors: Etta D Pisano; Constantine Gatsonis; Edward Hendrick; Martin Yaffe; Janet K Baum; Suddhasatta Acharyya; Emily F Conant; Laurie L Fajardo; Lawrence Bassett; Carl D'Orsi; Roberta Jong; Murray Rebner Journal: N Engl J Med Date: 2005-09-16 Impact factor: 91.245
Authors: D Dreossi; A Abrami; F Arfelli; P Bregant; K Casarin; V Chenda; M A Cova; R Longo; R-H Menk; E Quai; E Quaia; L Rigon; T Rokvic; D Sanabor; M Tonutti; G Tromba; A Vascotto; F Zanconati; E Castelli Journal: Eur J Radiol Date: 2008-07-09 Impact factor: 3.528